AIM
ACAD icon

Aigen Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Aigen Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,030
Closed -$277K – 692
2024
Q2 		$277K Sell
17,030
-33,478
-66% -$540K 0.05% 506
2024
Q1 		$934K Sell
50,508
-2,013
-4% -$49.9K 0.2% 153
2023
Q4 		$1.64M Buy
52,521
+37,455
+249% +$894K 0.29% 84
2023
Q3 		$314K Buy
+15,066
New +$409K 0.06% 510
2020
Q4 		– Sell
-20,360
Closed -$840K – 746
2020
Q3 		$840K Buy
+20,360
New +$879K 0.11% 299

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Aigen Investment Management's ACAD Position: Q3 2024 in Review

Aigen Investment Management sold out of Acadia Pharmaceuticals (ACAD) in Q3 2024, closing a stake of 17,030 shares — an estimated $277K sold.

Aigen Investment Management first reported a position in ACAD in Q3 2020 and held it in 5 quarters. The position peaked at $1.64M in Q4 2023. 256 funds tracked by Wall St. Rank hold ACAD as of Q3 2024.

  • Aigen Investment Management reported no remaining Acadia Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Aigen Investment Management sold 17,030 Acadia Pharmaceuticals shares in Q3 2024, an estimated $277K.
  • Aigen Investment Management first reported a position in Acadia Pharmaceuticals in Q3 2020 and held it in 5 quarters.
  • Aigen Investment Management's Acadia Pharmaceuticals position peaked at $1.64M in Q4 2023.
  • 256 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2024.

Based on Aigen Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.